Farringdon Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,514
Closed -$19.5K 477
2025
Q1
$19.5K Buy
+13,514
New +$19.5K 0.01% 321